Neoplasms, Colorectal Completed Phase 3 Trials for Capecitabine (DB01101)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01996306A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRCTreatment